New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...

OEM Automatic levererar helheten för vatten och avlopp

Med kompletta lösningar för vatten och avlopp bidrar OEM Automatic till att hålla både små och stora vattenverk i drift. Sortimentet omfattar allt från mätning ...

Affibody AB

Lonza

Del 4 i Advance serien: Produkter och system

Vi uppfyller dina specifika krav när standardlösningar inte räcker till.

J&J utökar cancerportföljen – köper Halda för 33 miljarder

Johnson & Johnson (J&J) stärker sin ställning inom cancerområdet genom att köpa det privatägda Halda Therapeutics för motsvarande 33 miljarder kronor. Affären ä...

Novo Nordisk establishes new factory in Denmark

Novo Nordisk establishes a new production facility in Odense, Denmark, an investment of 8.5 billion Danish kroner.

Driftsäker nivå- och flödesmätning med Rosemount 1208

OEM Automatic presenterar Rosemount 1208 – en ny beröringsfri radar som förenar hög precision med enkel installation. Oavsett om det gäller vatten, livsmedel el...

BioProTT Clamp-On SL beröringsfria flödesgivare

BioProTT Clamp-On SL beröringsfria flödesgivare för single-use bioprocessteknik – från PSG Biotech.

600 million SEK for life science - "Should not be the country of moderation"

Sweden will prioritize excellence over breadth in research. This was made clear when the government presented the research proposition for the next four years.

She is CSL Behring's new Nordic General Manager

Since the beginning of january, Helena Bragd is the new Nordic General Manager for the biotech company CSL Behring and CEO of CSL Behring AB.

Drug development booms in Medicon Valley

When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on commission for pharmaceutical compani...

Speed meets precision for high-density components

ZEISS METROTOM 800 320 kV.

RegFile AB

Lundbeck presenterar första behandlingen mot MSA

Danska läkemedelsbolaget Lundbeck har utvecklat antikroppen amlenetug, som kan innebära den första behandling av multipel systematrofi (MSA).

Trends and overview: ELRIG "Robotics and Automation"

Laboratories on the way to end-to-end automation: Robotics, artificial intelligence and automation technology boosted by pandemic

Pharma Outsourcing – Find the Right Partner (2026)

Orbán's extended arm becomes health commissioner in the EU

Hungarian Olivér Várhelyi may soon become the most influential official for the healthcare and pharmaceutical industry in the EU. Várhelyi, who is close to Hung...

QPS Netherlands B.V

Artificial intelligence in radiology – “Risk prediction is very exciting”

A growing number of solutions based on artificial intelligence are being developed and used in healthcare. According to Sophia Zackrisson, Professor of Radiolog...

GSK acquires oncology research company

GSK acquires the American biotechnology company Idrx for up to 1.15 billion dollars.

Kompauto Nordic AB

Merck Life Science A/S

MSD discontinues development of cancer drugs after trial failures

MSD suspends Phase 3 trials for two drug programs for different forms of cancer after trial failures.